AAAAAA

   
Results: 1-10 |
Results: 10
THE USE OF AN ENTERAL EXPERT-SYSTEM IN THE PRESCRIPTION OF ENTERAL FORMULAS IN A UNIVERSITY HOSPITAL
Authors: MORGAN SL VAUGHN WH THOMPSON G HSU CC HARDIN JM
Citation: Sl. Morgan et al., THE USE OF AN ENTERAL EXPERT-SYSTEM IN THE PRESCRIPTION OF ENTERAL FORMULAS IN A UNIVERSITY HOSPITAL, Nutrition, 13(3), 1997, pp. 196-201
HOMOCYSTEINE (HCY), FOLATE (FA) AND VITAMIN-B-12 (BI2) IN PATIENTS RECEIVING AN ANTICONVULSANT
Authors: JOHNSTON KE TAMURA T VAUGHN WH FAUGHT E
Citation: Ke. Johnston et al., HOMOCYSTEINE (HCY), FOLATE (FA) AND VITAMIN-B-12 (BI2) IN PATIENTS RECEIVING AN ANTICONVULSANT, The FASEB journal, 11(3), 1997, pp. 1358-1358
COFACTOR ROLE FOR 10-FORMYL-7,8-DIHYDROFOLATE (10-HCO-H(2)FOLATE)
Authors: BAGGOTT JE JOHANNING GL PRINCE CW MORGAN SL VAUGHN WH BRANHAM KE
Citation: Je. Baggott et al., COFACTOR ROLE FOR 10-FORMYL-7,8-DIHYDROFOLATE (10-HCO-H(2)FOLATE), The FASEB journal, 9(3), 1995, pp. 155-155
COFACTOR ROLE FOR 10-FORMYLDIHYDROFOLIC ACID
Authors: BAGGOTT JE JOHANNING GL BRANHAM KE PRINCE CW MORGAN SL ETO I VAUGHN WH
Citation: Je. Baggott et al., COFACTOR ROLE FOR 10-FORMYLDIHYDROFOLIC ACID, Biochemical journal, 308, 1995, pp. 1031-1036
PLASMA FOLATE CONJUGASE ACTIVITIES AND FOLATE CONCENTRATIONS IN PATIENTS RECEIVING HEMODIALYSIS
Authors: LIVANT EJ TAMURA T JOHNSTON KE VAUGHN WH BERGMANN SM FOREHAND J WALTHAW J
Citation: Ej. Livant et al., PLASMA FOLATE CONJUGASE ACTIVITIES AND FOLATE CONCENTRATIONS IN PATIENTS RECEIVING HEMODIALYSIS, Journal of nutritional biochemistry, 5(10), 1994, pp. 504-508
HEAT-STABLE FOLATE CONJUGASE INHIBITOR IN PRE-HEMODIALYSIS PLASMA OF PATIENTS WITH END-STAGE RENAL-DISEASE
Authors: TAMURA T LIYANT EJ JOHNSTON KE VAUGHN WH BERGMAN SM BAGWELL J WALTHAW J
Citation: T. Tamura et al., HEAT-STABLE FOLATE CONJUGASE INHIBITOR IN PRE-HEMODIALYSIS PLASMA OF PATIENTS WITH END-STAGE RENAL-DISEASE, The FASEB journal, 8(5), 1994, pp. 10000704-10000704
DIFFERENCES IN METHOTREXATE AND 7-HYDROXYMETHOTREXATE INHIBITION OF FOLATE-DEPENDENT ENZYMES OF PURINE NUCLEOTIDE BIOSYNTHESIS
Authors: BAGGOTT JE MORGAN SL VAUGHN WH
Citation: Je. Baggott et al., DIFFERENCES IN METHOTREXATE AND 7-HYDROXYMETHOTREXATE INHIBITION OF FOLATE-DEPENDENT ENZYMES OF PURINE NUCLEOTIDE BIOSYNTHESIS, Biochemical journal, 300, 1994, pp. 627-629
SUPPLEMENTATION WITH FOLIC-ACID DARING METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: MORGAN SL BAGGOTT JE VAUGHN WH AUSTIN JS VEITCH TA LEE JY KOOPMAN WJ KRUMDIECK CL ALARCON GS
Citation: Sl. Morgan et al., SUPPLEMENTATION WITH FOLIC-ACID DARING METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 121(11), 1994, pp. 833-841
MODIFICATION OF A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR ASSAY OF HOMOCYSTEINE IN HUMAN PLASMA
Authors: CORNWELL PE MORGAN SL VAUGHN WH
Citation: Pe. Cornwell et al., MODIFICATION OF A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR ASSAY OF HOMOCYSTEINE IN HUMAN PLASMA, Journal of chromatography. Biomedical applications, 617(1), 1993, pp. 136-139
5 MG OR 50 MG WEEK OF FOLIC-ACID (FA) SUPPLEMENTATION DOES NOT ALTER THE EFFICACY OF METHOTREXATE (MTX)-TREATED RHEUMATOID-ARTHRITIS (RA) PATIENTS/
Authors: MORGAN SL BAGGOTT JE VAUGHN WH AUSTIN JS VEITCH TA KRUMDIECK CL KOOPMAN WJ ALARCON GS
Citation: Sl. Morgan et al., 5 MG OR 50 MG WEEK OF FOLIC-ACID (FA) SUPPLEMENTATION DOES NOT ALTER THE EFFICACY OF METHOTREXATE (MTX)-TREATED RHEUMATOID-ARTHRITIS (RA) PATIENTS/, Arthritis and rheumatism, 36(9), 1993, pp. 190000079-190000079
Risultati: 1-10 |